Application | Comment | Organism |
---|---|---|
diagnostics | relative ratios of aryl acylamidase activity to butyrylcholinesterase activity on butyrylchlolinesterase protein could serve as a diagnostic marker in comparison to aspartate aminotransferases and gamma-glutamyltransferase activities, in patients with liver disorders | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
iso-ompa | inhibitor of butyrylcholinesterase (BChE), also inhibits aryl acylamidase activity | Homo sapiens | |
serotonin | inhibitor of butyrylcholinesterase (BChE), also inhibits aryl acylamidase activity | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
brain | - |
Homo sapiens | - |
liver | - |
Homo sapiens | - |
serum | - |
Homo sapiens | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
0.328 | - |
control serum samples from patients with normal levels of butyrylcholinesterase | Homo sapiens |
0.331 | - |
control serum samples from patients with normal levels of butyrylcholinesterase | Homo sapiens |
0.455 | - |
control serum samples from patients with normal levels of butyrylcholinesterase | Homo sapiens |
0.621 | - |
control serum samples from patients with normal levels of butyrylcholinesterase | Homo sapiens |
0.649 | - |
serum samples of patients with liver dysfunction | Homo sapiens |
0.665 | - |
serum samples of patients with liver dysfunction | Homo sapiens |
0.741 | - |
serum samples of patients with liver dysfunction | Homo sapiens |
0.804 | - |
serum samples of patients with liver dysfunction | Homo sapiens |
0.806 | - |
serum samples of patients with liver dysfunction | Homo sapiens |
0.904 | - |
serum samples of patients with liver dysfunction | Homo sapiens |
0.981 | - |
control serum samples from patients with normal levels of butyrylcholinesterase | Homo sapiens |
1.061 | - |
serum samples of patients with pathological liver dysfunction | Homo sapiens |
1.116 | - |
serum samples of patients with pathological liver dysfunction | Homo sapiens |
1.236 | - |
serum samples of patients with liver dysfunction | Homo sapiens |
1.381 | - |
serum samples of patients with pathological liver dysfunction | Homo sapiens |
1.477 | - |
serum samples of patients with pathological liver dysfunction | Homo sapiens |
1.503 | - |
serum samples of patients with pathological liver dysfunction | Homo sapiens |
2.809 | - |
serum samples of patients with pathological liver dysfunction | Homo sapiens |
3.244 | - |
serum samples of patients with pathological liver dysfunction | Homo sapiens |
3.785 | - |
serum samples of patients with pathological liver dysfunction | Homo sapiens |
4.068 | - |
serum samples of patients with pathological liver dysfunction | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
o-nitroacetanilide + H2O | - |
Homo sapiens | 2-nitroaniline + acetate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
AAA | - |
Homo sapiens |
aryl acylamidase | - |
Homo sapiens |